|A service of the U.S. National Library of Medicine®|
What are the ethical issues surrounding gene therapy?
Because gene therapy involves making changes to the body’s set of basic instructions, it raises many unique ethical concerns. The ethical questions surrounding gene therapy include:
Current gene therapy research has focused on treating individuals by targeting the therapy to body cells such as bone marrow or blood cells. This type of gene therapy cannot be passed on to a person’s children. Gene therapy could be targeted to egg and sperm cells (germ cells), however, which would allow the inserted gene to be passed on to future generations. This approach is known as germline gene therapy.
The idea of germline gene therapy is controversial. While it could spare future generations in a family from having a particular genetic disorder, it might affect the development of a fetus in unexpected ways or have long-term side effects that are not yet known. Because people who would be affected by germline gene therapy are not yet born, they can’t choose whether to have the treatment. Because of these ethical concerns, the U.S. Government does not allow federal funds to be used for research on germline gene therapy in people.
For more information about the ethical issues raised by gene therapy:
The Genetics and Public Policy Center outlines scientific issues and ethical concerns regarding gene
The National Human Genome Research Institute discusses scientific issues and ethical concerns surrounding germline gene
A discussion of the ethics of gene therapy and genetic